Blog
The AMCP Blog is your go-to resource to hear from managed care experts and their perspectives on trends and hot topics related to managed care pharmacy.
AMCP's Steve Kheloussi updates members of the MCP community on the newest resources for the managed care pharmacy toolbox.
With Vice President Kamala Harris likely to receive the Democratic nomination, we outline the health policy positions she has supported as a Senator, Vice President, and in her 2020 presidential campaign.
AMCP was honored to partner with The Skin of Color Society to develop two invaluable resources focusing on immune-mediated skin conditions — atopic dermatitis (AD) and alopecia areata (AA) — within the context of skin color, social determinants of health (SDOH), and health disparities. AMCP Director, Educational Programs/Grants Jennifer Evans, PharmD, BCACP, offers valuable insight into how to start bridging the gaps in care for these skin conditions in her latest blog post.
AMCP member advocates from across the country took to Capitol Hill to speak with lawmakers about ways to improve patient access to innovative new treatments as well as critical pharmacy legislation.
More than 3,500 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in New Orleans from April 15-18 for AMCP 2024, the industry’s largest and most impactful annual meeting. Attendees connected with like-minded professionals, discussed the important trends impacting their work, and expanded their horizons through cutting-edge education sessions.
In 2021, the AMCP Listen Up! podcast was introduced to keep health care leaders updated on the latest developments in our rapidly evolving health care system. It focuses on new pharmaceuticals, policies, payment models, and integrated delivery systems. Here are three reasons why listening to this podcast can enhance your knowledge of the managed care pharmacy landscape.
This Valentine’s Day we are showing our appreciation for the dedicated managed care professionals —medical directors, pharmacists, nurses, case managers, health care administrators and more — who work every day to optimize and improve patient health.
The Academy of Managed Care Pharmacy (AMCP) reflects on a year marked by triumphs, innovation and notable acheivements and looks forward toward the potential opportunities and challenges awaiting managed care professionals in 2024.
In a historic decision in December, the FDA approved the first gene therapy utilizing CRISPR, an innovative type of genome editing technology. This significant moment means that the novel therapy Casgevy is approved for the treatment of sickle cell disease—which affects 100,000 Americans—in patients 12 years of age and older.
The MVP Act is a top federal policy priority for AMCP. This important bipartisan bill will enhance Medicaid patient access to new, high-cost therapies by modernizing the framework for value-based purchasing arrangements.
AMCP's most recent Partnership Forum drew participants from a range of backgrounds and perspectives to discuss the value of collaboration between health plans/payers and patient advocacy organizations in managed care pharmacy decision-making. Senior VP of Professional and Government Affairs Jennifer Mathieu shares key insights and takeaways from the event.
JMCP’s Editor-in-Chief shares three reasons to check out JMCP’s new website, including the Managed Care Pharmacy Primer Series, timely papers on implementation of the IRA, and JMCP’s policy on AI.
